Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Oct 16, 2021; 13(10): 491-501
Published online Oct 16, 2021. doi: 10.4253/wjge.v13.i10.491
Published online Oct 16, 2021. doi: 10.4253/wjge.v13.i10.491
Clinical impact of gastrointestinal endoscopy on the early detection of pharyngeal squamous cell carcinoma: A retrospective cohort study
Hideaki Miyamoto, Hideaki Naoe, Kensuke Sakisaka, Sayoko Tayama, Kenshi Matsuno, Ryosuke Gushima, Masakuni Tateyama, Yasuhito Tanaka, Department of Gastroenterology and Hepatology, Kumamoto University Hospital, Kumamoto 860-8556, Japan
Jun Morinaga, Department of Clinical Investigation, Kumamoto University Hospital, Kumamoto 860-8556, Japan
Takashi Shono, Department of Gastroenterology, Kumamoto Chuo Hospital, Kumamoto 860-8556, Japan
Masanori Imuta, Department of Radiology, Kumamoto University Hospital, Kumamoto 860-8556, Japan
Satoru Miyamaru, Daizo Murakami, Yorihisa Orita, Department of Otolaryngology-Head and Neck Surgery, Kumamoto University Hospital, Kumamoto 860-8556, Japan
Author contributions: Miyamoto H, Naoe H, Morinaga J, Shono T and Tanaka Y were involved in the analysis and interpretation of data and drafting the manuscript; Sakisaka K, Tayama S, Matsuno K and Gushima R participated in the study coordination and acquisition of data; Tateyama M, Imuta I, Miyamaru S, Murakami D, and Orita Y critically revised the manuscript for important intellectual content; Tanaka Y approved the final version of the article for publication; All authors approved the final version.
Institutional review board statement: This study has been ethically approved by the Kumamoto University Ethics Committee (Approval No. 1851).
Conflict-of-interest statement: The authors declare no conflicts of interest associated with this manuscript.
Data sharing statement: All data relevant to the study are included in the article. No additional data available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yasuhito Tanaka, MD, Professor, Department of Gastroenterology and Hepatology, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. ytanaka@kumamoto-u.ac.jp
Received: March 6, 2021
Peer-review started: March 6, 2021
First decision: July 3, 2021
Revised: July 26, 2021
Accepted: September 16, 2021
Article in press: September 16, 2021
Published online: October 16, 2021
Processing time: 222 Days and 0.9 Hours
Peer-review started: March 6, 2021
First decision: July 3, 2021
Revised: July 26, 2021
Accepted: September 16, 2021
Article in press: September 16, 2021
Published online: October 16, 2021
Processing time: 222 Days and 0.9 Hours
Core Tip
Core Tip: This is the first study to explore the detection modality of oropharyngeal and hypopharyngeal squamous cell carcinomas (SCC). In this study, 31.4% of pharyngeal SCCs (15.4% of oropharyngeal SCCs and 42.3% of hypopharyngeal SCCs) were detected by gastrointestinal endoscopy. The clinical characteristics of the lesions detected by gastrointestinal endoscopy include a higher proportion of asymptomatic cases, cTis-1 cases, cases with no lymph node metastasis and cases treated by endoscopic laryngo-pharyngeal surgery/endoscopic submucosal dissection, leading to a better prognosis. This study highlights the important role of gastrointestinal endoscopy in the early detection and treatment of SCC in the otolaryngology field.